{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:30:24Z","timestamp":1787686224925,"version":"build-2784847793"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100008648","name":"Pfizer Foundation","doi-asserted-by":"publisher","award":["MAPP-034284"],"award-info":[{"award-number":["MAPP-034284"]}],"id":[{"id":"10.13039\/100008648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022110","name":"bioM\u00e9rieux","doi-asserted-by":"publisher","award":["1862 and E0878"],"award-info":[{"award-number":["1862 and E0878"]}],"id":[{"id":"10.13039\/501100022110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2025,11,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Ceftazidime\/avibactam (CZA) is a promising treatment option for infections caused by carbapenem-resistant Enterobacterales (CRE). However, CZA resistance is increasingly reported worldwide, largely due to the emergence of KPC variants and increase of metallo-\u03b2-lactamases (MBL). This study describes the mechanisms associated with CZA resistance in circulating Enterobacterales isolates from Colombia, highlighting the challenge this represents for microbiological identification. Between 2021 and 2024, 68 CZA-resistant Enterobacterales isolates were identified by automated methods in seven Colombian cities. Resistance to CZA was subsequently confirmed by broth microdilution and E-test. Carbapenemase production was evaluated using phenotypic tests, such as the mCIM test, Carba NP, lateral flow assay, and qPCR (\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>KPC<\/jats:sub>\n                      ,\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>NDM<\/jats:sub>\n                      ,\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>VIM<\/jats:sub>\n                      ,\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>IMP<\/jats:sub>\n                      , and\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>OXA-48<\/jats:sub>\n                      ). Whole-genome sequencing was performed on 15 isolates that tested negative for MBL genes. Whole-genome sequencing of these 15 isolates revealed a variety of resistance determinants: six isolates harbored\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>KPC-31<\/jats:sub>\n                      , one\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>KPC-33<\/jats:sub>\n                      <jats:italic toggle=\"yes\">,<\/jats:italic>\n                      one\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>KPC-8<\/jats:sub>\n                      , five harbored\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>PAC-2<\/jats:sub>\n                      , and two co-harbored\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>PAC-2<\/jats:sub>\n                      and\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>KPC-2<\/jats:sub>\n                      . Notably,\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>PAC-2<\/jats:sub>\n                      was located on an IncQ plasmid. However, some of these variants were not detected by phenotypic assays, likely due to their low or undetectable carbapenemase activity. CZA resistance in non-MBL producing Enterobacterales in Colombia is primarily mediated by the presence of\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>KPC-31<\/jats:sub>\n                      and emergence of\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>PAC-2<\/jats:sub>\n                      . These resistance mechanisms pose significant diagnostic, therapeutic, and epidemiological challenges, as they frequently go undetected by conventional microbiological methods. In this context, enhanced molecular surveillance and improved diagnostic strategies are urgently needed to enable early detection, guide antimicrobial therapy, and support infection control and stewardship efforts.\n                    <\/jats:p>\n                    <jats:sec>\n                      <jats:title>IMPORTANCE<\/jats:title>\n                      <jats:p>Antibiotic resistance is a serious global health threat. Ceftazidime\/avibactam (CZA) is a key treatment option for multidrug-resistant (MDR) Enterobacterales often used when other antibiotics fail. However, bacteria are now developing resistance to this drug as well, making infections increasingly difficult to treat. In this study, we examined CZA-resistant bacteria from multiple cities in Colombia and found uncommon resistance genes across several bacterial species. These genes are frequently missed, as they often do not test positive due to the limitations of most routinely used laboratory tests. Importantly, some of these genes can be transferred between bacteria, increasing the likelihood of indiscriminate dissemination in the hospital setting. Therefore, our findings highlight the urgent need for improved diagnostic tools and molecular surveillance. Early detection will help physicians select effective treatments quickly and prevent the wider dissemination of these MDR-resistant bacteria.<\/jats:p>\n                    <\/jats:sec>\n                  <\/jats:sec>","DOI":"10.1128\/spectrum.01805-25","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:06:04Z","timestamp":1760101564000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["Emergence and dissemination of\n                    <i>bla<\/i>\n                    <sub>KPC-31<\/sub>\n                    and\n                    <i>bla<\/i>\n                    <sub>PAC-2<\/sub>\n                    among different species of Enterobacterales in Colombia: a new challenge for the microbiological laboratories"],"prefix":"10.1128","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1179-5382","authenticated-orcid":true,"given":"Betsy E.","family":"Castro","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04m9gzq43","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaciones en Resistencia Antimicrobiana y Epidemiolog\u00eda Hospitalaria (RAEH), Universidad El Bosque","place":["Bogot\u00e1 D.C., Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0361-7893","authenticated-orcid":true,"given":"Elsa","family":"De la Cadena","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04m9gzq43","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaciones en Resistencia Antimicrobiana y Epidemiolog\u00eda Hospitalaria (RAEH), Universidad El Bosque","place":["Bogot\u00e1 D.C., Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneth J.","family":"Escobar-Arcos","sequence":"additional","affiliation":[{"name":"Gesti\u00f3n Pre-Transfusional Laboratorio y Patolog\u00eda, Cl\u00ednica Imbanaco Grupo Quir\u00f3nsalud","place":["Cali, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5569-6031","authenticated-orcid":true,"given":"Juan C.","family":"Garc\u00eda-Betancur","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04m9gzq43","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaciones en Resistencia Antimicrobiana y Epidemiolog\u00eda Hospitalaria (RAEH), Universidad El Bosque","place":["Bogot\u00e1 D.C., Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9784-6700","authenticated-orcid":true,"given":"Natalia","family":"Restrepo-Arbel\u00e1ez","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04m9gzq43","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaciones en Resistencia Antimicrobiana y Epidemiolog\u00eda Hospitalaria (RAEH), Universidad El Bosque","place":["Bogot\u00e1 D.C., Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pallares","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04m9gzq43","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaciones en Resistencia Antimicrobiana y Epidemiolog\u00eda Hospitalaria (RAEH), Universidad El Bosque","place":["Bogot\u00e1 D.C., Colombia"]},{"name":"Comit\u00e9 de Infecciones y Vigilancia Epidemiol\u00f3gica, Cl\u00ednica Imbanaco Grupo Quir\u00f3nsalud","place":["Cali, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9865-9097","authenticated-orcid":true,"given":"Mar\u00eda J.","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Servicio de infectolog\u00eda, Centro de Tratamiento e Investigaci\u00f3n sobre el C\u00e1ncer Luis Carlos Sarmiento Angulo (CTIC)","place":["Bogot\u00e1, Colombia"]},{"id":[{"id":"https:\/\/ror.org\/04m9gzq43","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaciones GIGA, CTIC\/ Universidad El Bosque","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pescador","sequence":"additional","affiliation":[{"name":"Grupo de Investigaci\u00f3n en Medicina Cardiovascular y Especialidades de Alta Complejidad, Fundaci\u00f3n Cl\u00ednica SHAIO","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Escobar T.","sequence":"additional","affiliation":[{"name":"Hospital Federico Lleras Acosta","place":["Ibagu\u00e9, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Matta-Cortes","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00jb9vg53","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidad del Valle","place":["Cali, Colombia"]},{"name":"Hospital Universitario del Valle","place":["Cali, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana C.","family":"Palacios-Larrota","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00xdnjz02","id-type":"ROR","asserted-by":"publisher"}],"name":"Departamento de patolog\u00eda y medicina del laboratorio, Fundaci\u00f3n Valle del Lili","place":["Cali, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1898-9067","authenticated-orcid":true,"given":"Mar\u00eda Virginia","family":"Villegas","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04m9gzq43","id-type":"ROR","asserted-by":"publisher"}],"name":"Grupo de Investigaciones en Resistencia Antimicrobiana y Epidemiolog\u00eda Hospitalaria (RAEH), Universidad El Bosque","place":["Bogot\u00e1 D.C., Colombia"]},{"name":"Comit\u00e9 de Infecciones y Vigilancia Epidemiol\u00f3gica, Cl\u00ednica Imbanaco Grupo Quir\u00f3nsalud","place":["Cali, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1710.110655"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2020.1813023"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2016.1222343"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0902-x"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw243"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106679"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.12.009"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04105-23"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04111-23"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02414-21"},{"key":"e_1_3_4_13_2","unstructured":"Saavedra S Gutierrez MA Duarte C. 2024. Comunicado t\u00e9cnico vigilancia intensificada por laboratorio de resistencia a ceftazidima\/avibactam mediada por betalactamasas en Enterobacterales en Colombia. Available from: https:\/\/www.ins.gov.co\/BibliotecaDigital\/comunicado-tecnico-vigilancia-intensificada-por-laboratorio-de-resistencia-a-ceftazidimaavibactam-mediada-por-betalactamasas-en-enterobacterales-en-colombia.pdf"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00082-25"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01391-23"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01375-19"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2025.116716"},{"key":"e_1_3_4_18_2","volume-title":"Clinical and Laboratory Standards Institute. CLSI supplement M100. 35th ed","author":"CLSI","year":"2025","unstructured":"CLSI. 2025. Performance standards for antimicrobial susceptibility testing. In Clinical and Laboratory Standards Institute. CLSI supplement M100. 35th ed. Wayne, PA."},{"key":"e_1_3_4_19_2","unstructured":"Tigecycline \u2013 injection products. FDA. Available from: https:\/\/www.fda.gov\/drugs\/development-resources\/tigecycline-injection-products. Retrieved 2121 MayMay 2025. Accessed 2121 MayMay 2025"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01140-18"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03926-14"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/cmb.2012.0021"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000685"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-9-75"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.06094-11"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000748"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00419-13"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24448-3"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02412-14"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/gbe\/evx115"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03383-5"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00447-22"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2020.11.004"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2016.09.013"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2025.107540"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2015_5017"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02824-14"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.7705\/biomedica.7065"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/651670"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01494-24"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.01805-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.01805-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:07:21Z","timestamp":1762265241000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.01805-25"}},"subtitle":[],"editor":[{"given":"Gabriele","family":"Arcari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,4]]}},"alternative-id":["10.1128\/spectrum.01805-25"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.01805-25","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"2025-06-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01805-25"}}